ストックスクリーナーアプリを入手
0.4171
3.19%
0.0129
アフターアワーズ：
.42
0.0029
+0.70%
前日終値:
$0.4042
開ける：
$0.42
24時間の取引高:
154.05K
Relative Volume:
0.73
時価総額：
$9.15M
収益：
$4.03M
当期純損益:
$24.32M
株価収益率:
-0.097
EPS:
-4.3008
ネットキャッシュフロー:
$-45.76M
1週間 パフォーマンス:
-2.52%
1か月 パフォーマンス:
-3.31%
6か月 パフォーマンス:
-45.57%
1年 パフォーマンス:
-74.41%
1日の値動き範囲:
$0.406
$0.42
1週間の範囲:
$0.3919
$0.449
52週間の値動き範囲:
$0.304
$1.76
Pavmed Inc Stock (PAVM) Company Profile
PAVM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
0.4171 | 8.87M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
134.57 | 233.52B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.23 | 145.95B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
377.84 | 144.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.59 | 121.32B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.55 | 44.15B | 5.69B | 1.41B | 577.90M | 6.95 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-11-05 | 開始されました | Ascendiant Capital Markets | Buy |
| 2018-06-28 | 開始されました | Maxim Group | Buy |
Pavmed Inc (PAVM) 最新ニュース
Revenue Check: Will PAVmed Inc stock hit new highs in YEARJuly 2025 Rallies & Reliable Trade Execution Plans - khodrobank.com
PAVmed Reports Q2 2025 Financial Results and Developments - MSN
Short Covering: Is PAVmed Inc a stock for growth or value investorsQuarterly Investment Review & Weekly Momentum Picks - khodrobank.com
Weekly Recap: Will PAVmed Inc. benefit from sector rotation2025 Retail Activity & Free Risk Controlled Daily Trade Plans - khodrobank.com
Hedge Fund Moves: Is PAVmed Inc gaining market share2025 Momentum Check & Accurate Trade Setup Notifications - khodrobank.com
Volume Report: What makes PAVmed Inc stock attractive todayJuly 2025 WrapUp & Daily Profit Focused Screening - khodrobank.com
PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN
Key Medicare Coverage Decision Looms: Lucid Diagnostics Taps 25-Year Industry Veteran to Lead Market Access - Stock Titan
Resistance Check: Can PAVmed Inc expand into new marketsJuly 2025 Opening Moves & Smart Investment Allocation Tips - خودرو بانک
Revenue Check: What is PAVmed Incs market position2025 Growth vs Value & Weekly Market Pulse Alerts - khodrobank.com
Bearish Setup: Is OppFi Inc benefiting from interest rate changesWeekly Stock Report & Advanced Technical Signal Analysis - خودرو بانک
Earnings Risk: Will PAVmed Inc stock hit new highs in YEARMarket Rally & Free Safe Entry Trade Signal Reports - خودرو بانک
Aug Movers: Will PAVmed Inc. outperform during market ralliesJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - خودرو بانک
Targets Report: What makes PAVmed Inc stock attractive todayIndex Update & Daily Technical Stock Forecast Reports - khodrobank.com
Dow Update: Will PAVmed Inc benefit from rate cuts2025 Investor Takeaways & Low Volatility Stock Suggestions - خودرو بانک
Trade Report: Is PAVmed Inc a speculative investment2025 Buyback Activity & Accurate Trade Setup Notifications - خودرو بانک
Duke University to License Endoscopic Esophageal Imaging Tech to PAVmed - Medical Product Outsourcing
PAVmed’s Lucid Diagnostics Completes Public Stock Offering - TipRanks
Lucid Diagnostics Announces Public Stock Offering - MSN
Lucid Diagnostics Announces Closing of Public Offering of Common Stock - StreetInsider
Lucid Diagnostics Shares Fall After Pricing of Public Stock Offering - 富途牛牛
Lucid Diagnostics prices $25 million public offering of common stock - Investing.com
Lucid Prices Public Share Offering - Baystreet.ca
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - PR Newswire
Lucid Diagnostics prices $25 million public offering of common stock By Investing.com - Investing.com UK
Lucid Diagnostics announces proposed public offering of common stock By Investing.com - Investing.com Australia
Lucid Diagnostics announces proposed public offering of common stock - Investing.com
Lucid Diagnostics Plans Stock Offering - MarketScreener
Lucid Diagnostics Announces Proposed Public Offering Of Common Stock - Barchart.com
Transcript : Lucid Diagnostics Inc.Special Call - MarketScreener
Lucid Diagnostics Advances Towards Medicare Coverage - MSN
Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025 - BioSpace
What’s the outlook for PAVmed Inc.’s sectorWeekly Earnings Recap & Risk Adjusted Swing Trade Ideas - beatles.ru
How to build a dashboard for PAVmed Inc. stock2025 Stock Rankings & Weekly High Return Stock Opportunities - Newser
Risk Recap: Can PAVmed Inc. expand into new marketsEarnings Recap Summary & Consistent Return Strategy Ideas - 뉴스영
Will PAVmed Inc. outperform the marketNew Guidance & Daily Price Action Insights - Newser
Will PAVmed Inc. outperform during market rallies2025 Growth vs Value & Free Technical Confirmation Trade Alerts - خودرو بانک
Tools to assess PAVmed Inc.’s risk profileMarket Sentiment Review & Verified Technical Trade Signals - Newser
Analyzing recovery setups for PAVmed Inc. investors2025 Institutional Moves & Short-Term Trading Alerts - Newser
Key resistance and support levels for PAVmed Inc.Earnings Recap Summary & Fast Entry Momentum Trade Alerts - Newser
Tick level data insight on PAVmed Inc. volatilityWeekly Earnings Recap & Technical Entry and Exit Alerts - Newser
Buybacks Report: Is PAVmed Inc. stock a good pick for beginnersWeekly Stock Recap & Intraday High Probability Setup Alerts - خودرو بانک
Custom strategy builders for tracking PAVmed Inc.2025 Buyback Activity & Daily Profit Maximizing Trade Tips - Newser
Backtesting results for PAVmed Inc. trading strategiesJuly 2025 Spike Watch & Growth Focused Investment Plans - Newser
What does recent volatility data suggest for PAVmed Inc.Market Performance Recap & Technical Confirmation Trade Alerts - Newser
Custom watchlist performance reports with PAVmed Inc.Weekly Stock Summary & Expert Approved Momentum Trade Ideas - Newser
Critical Medicare Coverage Review: Lucid Diagnostics to Host Call on EsoGuard Cancer Detection Test Future - Stock Titan
Technical analysis overview for PAVmed Inc. stockRate Cut & Verified Momentum Stock Ideas - Newser
What institutional flow reveals about PAVmed Inc.July 2025 Action & High Accuracy Trade Signal Alerts - Newser
Pavmed Inc (PAVM) 財務データ
収益
当期純利益
現金流量
EPS
3.50%
0.86%
大文字化:
|
ボリューム (24 時間):